Principal Investigator
Enrollment Status
Clinical Trial ID
Clinical Trial Summary
This is a one year study to develop and test a culturally-tailored, web-based cognitive
behavioral stress management (CBSM) intervention for Latino sexual minority men living with
both HIV and cancer. Sexual minority Latino men living with HIV and cancer experience a
variety of health disparities related to their diagnoses, including higher distress. The
project will be a pilot randomized trial, comparing culturally-tailored CBSM to standard CBSM
for dually-diagnosed participants. The project will use a community-based participatory
research approach, and the investigators have included (and will continue to include)
LGBT-serving community partners in all phases of the research from study design to
implementation and dissemination of findings. The proposed study will aid in attenuating
health disparities among Latino sexual minority men living with HIV and cancer.
Phase
N/A
Funding Agency/Sponsor
Externally Peer-Reviewed
Disease
Prostate, Bladder, and Kidney Cancers
Enrollment Eligibility
Inclusion Criteria:
1. Have been diagnosed with at least one form of non-metastatic solid tumor cancer,
2. Are ≥ 30 days post active primary treatment (i.e. surgery, radiation, and/or
chemotherapy*) for their cancer. (Note: Adjuvant therapies, such as hormone therapy
for prostate cancer, etc. are not considered exclusionary),
3. Self-identify as a sexual minority man,
4. have been diagnosed with HIV,
5. Have reliable access to a computer/device with internet accessibility, and
6. Are fluent English.
Exclusion Criteria:
1. Have had one of the following exclusionary cancer types: Leukemia (or other cancers of
the blood), Non-melanoma skin cancer only (not in combination with another type listed
in the inclusion criteria above), Brain cancer, Eye cancer, a form of pediatric cancer
(if the pediatric cancer is the only cancer diagnosis the patient has had),
2. Have a history of advanced (metastatic) cancer of any type or are currently undergoing
primary treatment for their cancer,
3. Have had inpatient treatment for severe mental illness in the past 12 months, or have
overt signs of psychopathology (i.e. psychosis) and/or suicidality at the time of
screening,
4. Are experiencing active alcohol dependence, or have had inpatient treatment for
alcohol abuse within the past 12 months,
5. Are experiencing active substance dependence, or have had inpatient treatment for
substance abuse within the past 12 months, and/or
6. Have any other medical conditions resulting in a predicted life expectancy <12 months.